Early Access — free while we kick the tires
EdgarHawk

Jennifer A Phipps

Chief Financial Officer

Officer

Latest: CFO selling · June 2026

2 filings analyzed · 1 company · Latest 2026-06-05

Companies

Company Buys Sells Direction
BrightSpring Health Services, Inc. BTSG 0 5 Net selling

Activity

June 2026
Sell
35,000 shares
$2,056,250
Significance 5/10

CFO Jennifer A Phipps sells 35,000 BTSG shares at $58.75 for $2.1M; retains 250.2K shares plus 55,708 stock options.

Jennifer A Phipps, CFO of BrightSpring Health Services, sold 35,000 shares at $58.75 on 2026-06-05, reducing her non-derivative holdings from 285.2K to 250.2K shares (-12.3%). The sale occurred 7.6% below the 52-week high of $62.11, while the stock has gained 8.8% over the prior 30 days and 38.4% over 90 days. Her prior same-ticker sell on 2026-03-04 generated a 44.2% 90-day return after the transaction, indicating the stock rose following that sale. The company's fundamentals show strong growth: $3.6B in latest-quarter revenue with +14.6% annual revenue growth, though the P/E of 35.88 reflects elevated valuation relative to peers.

March 2026
Sell
35,000 shares
$1,440,250
Significance 4/10

CFO Jennifer A Phipps sells 35,000 BTSG shares at $41.15; retains 250,224 shares post-sale

Jennifer A Phipps, Chief Financial Officer, sold 35,000 shares (35.0K shares) of BrightSpring Health Services on 2026-03-04 at $41.15 for a total value of $1,440,250.00, reducing her holdings from 285,224 shares to 250,224 shares, a reduction of -12.3% from her pre-transaction position. The stock was trading at $41.49 at the time of analysis, and the sale price was -1.1% from the 52-week high of $41.96, indicating the shares were sold near peak valuation; over 30 and 90 days the stock has appreciated +11.3% and +15.9% respectively, reflecting positive recent momentum. The CFO's prior transaction at BTSG (a buy on 2024-03-14) delivered a 90-day return of +33.2%, demonstrating favorable historical timing at this ticker; the current sale occurred amid strong stock performance and after the company reported annual revenue growth of +14.6%, a market cap of $8,029,843,906.50, and a P/E ratio of 23.71. This is a routine, non-block sale by an executive retaining a material stake.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access